| Lastest Insider Transactions Of Replimune Group, Inc. ( REPL ) | |||||||||
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| REPL | Replimune Group, Inc. | Xynos Konstantinos | Chief Medical Officer | 2023-11-16 | Sell | 7,313 | 10.92 | 79,858 | 2023-11-17 20:01:13 |
| REPL | Replimune Group, Inc. | Sarchi Christopher | Chief Commercial Officer | 2023-11-16 | Sell | 5,255 | 10.92 | 57,385 | 2023-11-17 20:00:42 |
| REPL | Replimune Group, Inc. | Esposito Pamela | Chief Business Officer | 2023-09-11 | Sell | 5,658 | 20.01 | 113,214 | 2023-09-13 21:02:56 |
| REPL | Replimune Group, Inc. | Esposito Pamela | Chief Business Officer | 2023-09-11 | Option Exercise | 5,658 | 3.30 | 18,671 | 2023-09-13 21:02:56 |
| REPL | Replimune Group, Inc. | Esposito Pamela | Chief Business Officer | 2023-08-22 | Sell | 18,600 | 20.01 | 372,186 | 2023-08-24 20:30:30 |
| REPL | Replimune Group, Inc. | Esposito Pamela | Chief Business Officer | 2023-08-22 | Option Exercise | 18,600 | 6.58 | 122,380 | 2023-08-24 20:30:30 |
| REPL | Replimune Group, Inc. | Esposito Pamela | Chief Business Officer | 2023-08-11 | Sell | 1,400 | 20.00 | 28,000 | 2023-08-15 20:30:10 |
| REPL | Replimune Group, Inc. | Esposito Pamela | Chief Business Officer | 2023-08-11 | Option Exercise | 1,400 | 3.30 | 4,620 | 2023-08-15 20:30:10 |
| REPL | Replimune Group, Inc. | Esposito Pamela | Chief Business Officer | 2023-07-10 | Sell | 20,000 | 21.58 | 431,541 | 2023-07-11 21:00:14 |
| REPL | Replimune Group, Inc. | Esposito Pamela | Chief Business Officer | 2023-07-10 | Option Exercise | 20,000 | 6.35 | 127,000 | 2023-07-11 21:00:14 |
| REPL | Replimune Group, Inc. | Lewis Tanya | Chief Dev. Op. Officer | 2023-06-13 | Sell | 12,860 | 24.06 | 309,395 | 2023-06-15 21:01:04 |
| REPL | Replimune Group, Inc. | Patel Sushil | Chief Strategy Officer | 2023-06-13 | Sell | 5,698 | 24.04 | 137,008 | 2023-06-15 21:00:33 |
| REPL | Replimune Group, Inc. | Patel Sushil | Chief Strategy Officer | 2023-05-16 | Sell | 15,575 | 18.05 | 281,129 | 2023-05-18 20:36:09 |
| REPL | Replimune Group, Inc. | Coffin Robert | President & Chief R&D Officer | 2023-05-16 | Sell | 7,861 | 18.05 | 141,891 | 2023-05-18 20:35:22 |
| REPL | Replimune Group, Inc. | Lewis Tanya | Chief Dev. Op. Officer | 2023-05-16 | Sell | 12,207 | 18.05 | 220,336 | 2023-05-18 20:34:34 |
| REPL | Replimune Group, Inc. | Love Colin | Chief Operating Officer | 2023-05-16 | Sell | 10,775 | 18.05 | 194,489 | 2023-05-18 20:33:38 |
| REPL | Replimune Group, Inc. | Franchi Jean M. | Chief Financial Officer | 2023-05-16 | Sell | 11,351 | 18.05 | 204,886 | 2023-05-18 20:32:47 |
| REPL | Replimune Group, Inc. | Xynos Konstantinos | Chief Medical Officer | 2023-05-16 | Sell | 771 | 18.05 | 13,917 | 2023-05-18 20:31:48 |
| REPL | Replimune Group, Inc. | Esposito Pamela | Chief Business Officer | 2023-05-16 | Sell | 5,966 | 18.05 | 107,686 | 2023-05-18 20:31:06 |
| REPL | Replimune Group, Inc. | Astley-Sparke Philip | Chief Executive Officer | 2023-05-16 | Sell | 17,902 | 18.05 | 323,131 | 2023-05-18 20:30:25 |
| REPL | Replimune Group, Inc. | Esposito Pamela | Chief Business Officer | 2022-12-09 | Sell | 15,000 | 25.03 | 375,450 | 2022-12-13 20:01:12 |
| REPL | Replimune Group, Inc. | Esposito Pamela | Chief Business Officer | 2022-12-09 | Option Exercise | 15,000 | 1.01 | 15,150 | 2022-12-13 20:01:12 |
